AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 99 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $341,000 | -96.6% | 475,500 | -35.2% | 0.00% | -98.5% |
| Q2 2020 | $9,968,000 | -33.4% | 734,028 | -62.8% | 0.06% | -46.7% |
| Q1 2020 | $14,965,000 | +0.4% | 1,974,320 | -16.3% | 0.12% | +56.4% |
| Q4 2019 | $14,903,000 | +114.5% | 2,358,100 | +33.1% | 0.08% | +81.4% |
| Q3 2019 | $6,947,000 | -11.6% | 1,772,300 | +9.2% | 0.04% | +4.9% |
| Q2 2019 | $7,857,000 | +859.3% | 1,623,400 | +1523.4% | 0.04% | +925.0% |
| Q1 2019 | $819,000 | -70.6% | 100,000 | -80.2% | 0.00% | -71.4% |
| Q4 2018 | $2,789,000 | +5.9% | 504,373 | +69.1% | 0.01% | +27.3% |
| Q3 2018 | $2,633,000 | +42.3% | 298,212 | +53.6% | 0.01% | +37.5% |
| Q1 2018 | $1,850,000 | +184900.0% | 194,150 | +194050.0% | 0.01% | – |
| Q1 2016 | $1,000 | -99.8% | 100 | -99.8% | 0.00% | -100.0% |
| Q4 2015 | $543,000 | – | 42,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |